Alector Inc Revenue per Employee (ALEC), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Alector Inc   (NASDAQ: ALEC)
 

Alector Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


Alector Inc 's Revenue per employee fell on a trailing twelve month basis to $ 1,684,165, below the company average number of $824,609.
Within the Healthcare sector Employees of 412 other companies have achieved higher revenue per employee. While Alector Inc 's total ranking has deteriorated compared to the previous quarter from 1912 to 3133. Alector Inc has 103 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ALEC Revenue per Employee (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Revenue Change 4895.89 % -57.84 % -71.53 % -88.5 % -78.75 %
Sales per Employee (TTM) $ 1,684,165 134,592 178,806 204,320 670,369
ALEC's Total Ranking # 3133 # 1912 # 2393 # 1803 #
Seq. Revenue Change 4805.6 % 217.4 % -83.23 % 91.32 % -58.6 %

ALEC Company Profile >> Back to ALEC Efficiency Comparisons >> Compare ALEC Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 52
Healthcare Sector # 413
Overall Market # 3133

Revenue per Employee Statistics
High Average Low
$ 2,919,728 $ 824,609 $ 54,417
(Jun 30 2022)   (Mar 31 2019)



Financial Statements
Alector Inc 's Revenue MRQ $ 163 Millions Visit ALEC's Income Statement
Alector Inc 's Revenues TTM $ 173 Millions Visit ALEC's aggregate revenue growth
What are ALEC's Sales? Visit ALEC's Sales by Segment




Other Ratios
Alector Inc 's Income per Employee
Employees in Biotechnology & Pharmaceuticals
Biotechnology & Pharmaceuticals Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
ALEC's Revenue per Employee versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for ALEC's Competitors
Revenue per Employee for ALEC's Suppliers
Revenue per Employee for ALEC's Customers

You may also want to know
ALEC's Sales Growth Rates ALEC's Pe Price to earnings ratio ALEC's Receivables Turnover Ratio ALEC's Stock Quote
ALEC's Net Income Growth Rates ALEC's Ps Price to Sales ratio ALEC's Sales per Employee ALEC's Asset Turnover Ratio
ALEC's Net Margin ALEC's Pb Price to Book ratio ALEC's Financial Strength Ratios ALEC's Dividend Payout Ratio
Date modified: 2026-11-08T19:09:27+00:00




Companies with similar Revenue per Employee for 12 months ending Sep 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Sep 30 2026Number of Employees Sep 30 2026
Kiniksa Pharmaceuticals International Plc  2,584,598.36 $ 945.963  Million 366 
Aurinia Pharmaceuticals Inc   2,513,578.12 $ 321.738  Million 128 
Sarepta Therapeutics Inc   2,342,920.96 $ 1,956.339  Million 835 
Zevra Therapeutics Inc   2,304,065.57 $ 140.548  Million 61 
Nurix Therapeutics Inc   2,214,309.15 $ 701.936  Million 317 
Exelixis Inc   2,176,862.25 $ 2,496.861  Million 1,147 
Incyte Corporation  2,113,485.94 $ 6,010.754  Million 2,844 
Alnylam Pharmaceuticals Inc   2,005,296.80 $ 5,013.242  Million 2,500 
Neurocrine Biosciences Inc   1,850,850.00 $ 3,701.700  Million 2,000 
Tarsus Pharmaceuticals Inc   1,843,791.89 $ 682.203  Million 370 
Gilead Sciences Inc   1,822,823.53 $ 30,988.000  Million 17,000 
Mirum Pharmaceuticals Inc   1,803,166.67 $ 670.778  Million 372 
Eli Lilly And Company  1,729,240.00 $ 86,462.000  Million 50,000 
Alector Inc   1,684,165.05 $ 173.469  Million 103 
Rigel Pharmaceuticals Inc  1,656,396.55 $ 288.213  Million 174 
Jazz Pharmaceuticals Plc  1,632,569.55 $ 4,718.126  Million 2,890 
Krystal Biotech Inc   1,593,305.08 $ 470.025  Million 295 
Madrigal Pharmaceuticals Inc   1,560,590.16 $ 1,427.940  Million 915 
Bristol myers Squibb Company  1,539,476.92 $ 50,033.000  Million 32,500 
Acadia Pharmaceuticals Inc   1,506,642.86 $ 1,202.301  Million 798 
Indivior Pharmaceuticals Inc   1,376,000.00 $ 1,376.000  Million 1,000 
Biogen Inc   1,372,973.33 $ 10,297.300  Million 7,500 
Supernus Pharmaceuticals inc   1,326,849.69 $ 865.106  Million 652 
Corcept Therapeutics Inc  1,320,064.38 $ 963.647  Million 730 
Travere Therapeutics Inc   1,309,927.57 $ 651.034  Million 497 
Lantheus Holdings Inc   1,309,212.07 $ 1,561.890  Million 1,193 
Ptc Therapeutics inc   1,166,048.44 $ 1,155.554  Million 991 
Abbvie Inc   1,158,140.35 $ 66,014.000  Million 57,000 
Biomarin Pharmaceutical Inc  1,134,780.19 $ 3,655.127  Million 3,221 
Bridgebio Pharma Inc   1,126,984.51 $ 945.540  Million 839 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.